DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Zydus Wellness Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·4 Aug 2026, 1:49 pm

Zydus Wellness

Zydus Wellness has announced the schedule for its upcoming institutional investor meeting. The company has informed the stock exchanges about the date and time for this conference call, which is a standard procedure for publicly listed firms to engage with analysts and large shareholders.

This event is significant for investors as it provides an opportunity to hear management's strategic outlook directly. It typically covers recent performance, product pipeline updates, and future growth plans, helping the market gauge the company's direction ahead of earnings reports or key business milestones.

Investors should pay close attention to management's commentary on demand trends and margin expansion during the discussion. Any guidance provided could offer clues about the company's near-term performance and influence the stock's valuation.